Status: current, Primitive. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2633381000168114 | Piptaz 4 g/0.5 g (AFT) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2633391000168112 | Piptaz 4 g/0.5 g (AFT) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Piptaz 4 g/0.5 g (AFT) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | has TP | True | Piptaz 4 g/0.5 g (AFT) | Inferred relationship | Some | |
| Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | Is a | True | Piptaz 4 g/0.5 g (AFT) | Inferred relationship | Some | |
| Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | has TP | True | Piptaz 4 g/0.5 g (AFT) | Inferred relationship | Some | |
| Piptaz 4 g/0.5 g (AFT) powder for injection, 10 x 4.5 g vials | has TP | True | Piptaz 4 g/0.5 g (AFT) | Inferred relationship | Some | |
| Piptaz 4 g/0.5 g (AFT) (piperacillin 4 g + tazobactam 500 mg) powder for injection, 10 x 4.5 g vials (trade product pack) | has TP | True | Piptaz 4 g/0.5 g (AFT) | Inferred relationship | Some |
Reference Sets
FHIR